Ohio Public Employees Retirement System (OPERS)
IOVA icon

Ohio Public Employees Retirement System (OPERS)’s Iovance Biotherapeutics IOVA Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-82,830
Closed -$506K – 1993
2023
Q1 		$506K Buy
82,830
+58,624
+242% +$404K ﹤0.01% 1271
2022
Q4 		$155K Sell
24,206
-5,494
-18% -$42.9K ﹤0.01% 1432
2022
Q3 		$285K Buy
+29,700
New +$343K ﹤0.01% 1407
2022
Q2 		– Sell
-77,463
Closed -$1.29M – 2019
2022
Q1 		$1.29M Sell
77,463
-2,786
-3% -$43.1K ﹤0.01% 1200
2021
Q4 		$1.53M Sell
80,249
-1,971
-2% -$43.4K 0.01% 1175
2021
Q3 		$2.03M Sell
82,220
-667
-0.8% -$15.7K 0.01% 1114
2021
Q2 		$2.16M Buy
82,887
+9,712
+13% +$252K 0.01% 1110
2021
Q1 		$2.32M Buy
73,175
+5,475
+8% +$227K 0.01% 1021
2020
Q4 		$3.14M Buy
67,700
+13,027
+24% +$517K 0.01% 839
2020
Q3 		$1.8M Buy
54,673
+3,083
+6% +$94.5K 0.01% 907
2020
Q2 		$1.42M Buy
+51,590
New +$1.7M 0.01% 1039

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s IOVA Position: Q2 2023 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Iovance Biotherapeutics (IOVA) in Q2 2023, closing a stake of 82,830 shares — an estimated $506K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in IOVA in Q2 2020 and held it in 11 quarters. The position peaked at $3.14M in Q4 2020. 219 funds tracked by Wall St. Rank hold IOVA as of Q2 2023.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Iovance Biotherapeutics position as of Q2 2023 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 82,830 Iovance Biotherapeutics shares in Q2 2023, an estimated $506K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Iovance Biotherapeutics in Q2 2020 and held it in 11 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Iovance Biotherapeutics position peaked at $3.14M in Q4 2020.
  • 219 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2023.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2023, filed 15 Aug 2023.